Literature DB >> 8129797

Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis.

J P Pelletier1, F Mineau, J P Raynauld, J F Woessner, Z Gunja-Smith, J Martel-Pelletier.   

Abstract

OBJECTIVE: To examine the effect of intraarticular injections of methylprednisolone acetate (MA) on osteoarthritic lesions and chondrocyte stromelysin synthesis in experimental osteoarthritis (OA).
METHODS: In 15 mongrel dogs, the anterior cruciate ligament of the right knee was sectioned by a stab wound. Eight dogs received intraarticular injections of MA (20 mg) at the time of surgery and 4 weeks later; 7 had no treatment. The dogs were killed 8 weeks after surgery. Five normal dogs were used as controls. Macroscopic evaluation of the lesions, including measurements of osteophytes and areas of surface lesions on the condyles and plateaus, was conducted, along with histologic evaluation of the severity of lesions. Immunohistochemical analysis was carried out using a rabbit polyclonal antibody against stromelysin, followed by evaluation of matrix and chondrocyte staining using morphometric analysis.
RESULTS: Treatment with MA significantly reduced the incidence (P < 0.0004) and size (P < 0.0001) of osteophytes. The histologic grading of cartilage lesions was also significantly reduced both on condyles (P < 0.01) and on plateaus (P < 0.002). Immunohistochemical studies revealed, for OA cartilage, a marked increase (P < 0.002) in the percentage of chondrocytes positive for stromelysin and in the intensity of staining throughout all the layers of the cartilage, as well as specific matrix staining (P < 0.005). Treatment with MA reduced staining at both the chondrocyte (P < 0.002) and the matrix (P < 0.01) levels toward normal.
CONCLUSION: These findings provide additional evidence for the protective effect of corticosteroid injections on OA lesions, and indicate that the effect of this drug may be mediated through the suppression of stromelysin synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129797     DOI: 10.1002/art.1780370316

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  27 in total

Review 1.  Pharmacologic therapy of osteoarthritis.

Authors:  J P Pelletier; D Choquette; B Haraoui; J P Raynauld; E Rich; J C Fernandes; J Martel-Pelletier
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 2.  Clinical assessment and significance of inflammation in knee osteoarthritis.

Authors:  V T Baddour; J D Bradley
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 3.  Intra-articular therapy in osteoarthritis.

Authors:  I Uthman; J-P Raynauld; B Haraoui
Journal:  Postgrad Med J       Date:  2003-08       Impact factor: 2.401

4.  Increased chondrocyte death after steroid and local anesthetic combination.

Authors:  Boglárka Farkas; Krisztián Kvell; Tamás Czömpöly; Tamás Illés; Tamás Bárdos
Journal:  Clin Orthop Relat Res       Date:  2010-08-11       Impact factor: 4.176

5.  The chondrotoxicity of single-dose corticosteroids.

Authors:  Jason L Dragoo; Christina M Danial; Hillary J Braun; Michael A Pouliot; Hyeon Joo Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-12-21       Impact factor: 4.342

Review 6.  Effect of various factors on articular cartilage and their implications on arthroscopic procedures: A review of literature.

Authors:  Sandeep Kohli; Varun Tandra; Abhinav Gulihar
Journal:  J Clin Orthop Trauma       Date:  2019-06-20

7.  Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study.

Authors:  Johannes T H Nielen; Frank de Vries; Pieter C Dagnelie; Bart J F van den Bemt; Pieter J Emans; Arief Lalmohamed; Anthonius de Boer; Annelies Boonen
Journal:  Br J Clin Pharmacol       Date:  2015-11-04       Impact factor: 4.335

8.  Acetylsalicylic acid combined with diclofenac inhibits cartilage degradation in rabbit models of osteoarthritis.

Authors:  Jianqiang Liu; Changshun Wu; Dong Wang; Laicheng Wang; Shui Sun
Journal:  Exp Ther Med       Date:  2016-08-01       Impact factor: 2.447

9.  Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis.

Authors:  D Lajeunesse; J Martel-Pelletier; J C Fernandes; S Laufer; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

10.  Physiological levels of hydrocortisone maintain an optimal chondrocyte extracellular matrix metabolism.

Authors:  J Wang; D Elewaut; I Hoffman; E M Veys; G Verbruggen
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.